Omegawave is a technology company.
Omegawave has raised $2.0M across 1 funding round.
Omegawave has raised $2.0M in total across 1 funding round.
Omegawave is a technology company that develops non-invasive wearable devices and software to assess athletes' brain and heart functions, providing readiness metrics for optimal training.[1][2][5] Its products, like Coach+ and Personal, analyze ECG for heart rate variability (HRV) and DC-EEG for central nervous system (CNS) status, serving coaches, personal trainers, physiotherapists, medical doctors, tactical teams, and individual athletes in sports science and fitness.[3][4][5][6] The system solves overtraining and recovery issues by delivering 4-minute assessments that recommend training types—such as endurance, speed/power, strength, or coordination—based on physiological data, with strong research backing improved performance outcomes like vertical jump power and running efficiency.[3][5]
Omegawave was founded in 1999 as OmegaWave Sport Inc. in Portland, Oregon, USA, by Leo Masakov, Val Nasedkin, and Allen K. Huffstutter, drawing from Soviet sports science and cosmonaut training research.[2] The technology, developed by Vladimir Larionov and Leonid Masakov, emerged from the need for non-invasive testing to replace stressful Soviet-era methods like muscle biopsies and exhaustion exercises, enabling frequent athlete condition checks.[2] In 2012, the company relocated to Espoo, Finland, rebranded as Omegawave Ltd., and secured investment from Sitra and Conor Venture Partners; key founders Masakov (Research Director) and Nasedkin (VP Business Development) moved to continue development.[2] Early recognition came in 2013 when Talouselämä listed it among Finland's most promising startups.[2]
Omegawave rides the wave of precision sports science and wearable biometrics, aligning with trends in personalized training amid rising athlete data demands in elite sports, military, and tactical fields.[1][3][4] Its timing leverages advances in affordable EEG/ECG sensors and AI-driven analysis, differentiating from general fitness trackers by offering clinical-grade, non-stressful diagnostics in a portable form.[2][3] Market forces like growing emphasis on recovery (post-overtraining injuries) and evidence-based coaching favor it, as seen in competitors like Equivital and Cogwear focusing on similar physiological monitoring.[1] It influences the ecosystem by enabling physiology-based program design, reducing wasted training, and supporting holistic models that integrate breath, stress, and adaptation tracking.[3]
Omegawave's edge in brain-heart synergy positions it for expansion into tactical and clinical markets, with potential integrations in AI coaching platforms and broader wellness apps. Trends like real-time biofeedback and longitudinal athlete data will amplify its role, especially as sports tech shifts toward predictive recovery. Its influence may grow through partnerships with pro teams and research validation, evolving from niche tool to standard in performance optimization—building on its Soviet roots to redefine daily training precision.
Omegawave has raised $2.0M in total across 1 funding round.
Omegawave's investors include Conor Venture Partners.
Omegawave has raised $2.0M across 1 funding round. Most recently, it raised $2.0M Seed in June 2013.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 1, 2013 | $2.0M Seed | Conor Venture Partners |